Patients With Autoimmune Hepatitis Who Have Antimitochondrial Antibodies Need Long-term Follow-up to Detect Late Development of Primary Biliary Cirrhosis

Clinical Gastroenterology and Hepatology

Volumn 10, Issue 6, 2012, Pages 682-684

  Dinani, Amreen M ^a   Fischer, Sandra E ^a   Mosko, Jeff ^a   Guindi, Maha ^a,b   Hirschfield, Gideon M ^a,c  

^a UNIVERSITY OF TORONTO   (Canada)

^b Sinai Medical Center   (United States)

^c UNIVERSITY OF BIRMINGHAM   (United Kingdom)

Author keywords

Autoimmunity; Clinical Care; Diagnosis; Disease Progression

Indexed keywords

ANTINUCLEAR ANTIBODY; IMMUNOGLOBULIN; MITOCHONDRIAL PROTEIN; MITOCHONDRION ANTIBODY; MOXIFLOXACIN;

ADULT; AGED; ARTICLE; AUTOIMMUNE HEPATITIS; BILE DUCT DISEASE; CASE REPORT; CLINICAL FEATURE; DISEASE COURSE; FEMALE; FOLLOW UP; HEALTH CARE PERSONNEL; HEPATITIS; HUMAN; HUMAN TISSUE; IMMUNOFLUORESCENCE; LIVER BIOPSY; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIMARY BILIARY CIRRHOSIS;

AGED; ANTIBODIES; DISEASE PROGRESSION; FEMALE; FOLLOW-UP STUDIES; HEPATITIS, AUTOIMMUNE; HISTOCYTOCHEMISTRY; HUMANS; IMMUNOHISTOCHEMISTRY; LIVER; LIVER CIRRHOSIS, BILIARY; MICROSCOPY; MIDDLE AGED; MITOCHONDRIA;

EID: 84861337118     PISSN: 15423565     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cgh.2012.02.010     Document Type: Article

References (15)

1. Bonder A., Retana A., Winston D.M., et al. Prevalence of primary biliary cirrhosis-autoimmune hepatitis overlap syndrome. Clin Gastroenterol Hepatol 2011, 9:609-612.
2. Gossard A.A., Lindor K.D. Development of autoimmune hepatitis in primary biliary cirrhosis. Liver Int 2007, 27:1086-1090.
3. Chazouillères O., Wendum D., Serfaty L., et al. Primary biliary cirrhosis-autoimmune hepatitis overlap syndrome: clinical features and response to therapy. Hepatology 1998, 28:296-301.
4. Heurgué A., Vitry F., Diebold M.D., et al. Overlap syndrome of primary biliary cirrhosis and autoimmune hepatitis: a retrospective study of 115 cases of autoimmune liver disease. Gastroenterol Clin Biol 2007, 31:17-25.
5. Boberg K.M., Chapman R.W., Hirschfield G.M., et al. Overlap syndromes: the International Autoimmune Hepatitis Group (IAIHG) position statement on a controversial issue. J Hepatol 2011, 54:374-385.
6. O'Brien C., Joshi S., Feld J.J., et al. Long-term follow-up of antimitochondrial antibody-positive autoimmune hepatitis. Hepatology 2008, 48:550-556.
7. Decock S., McGee P., Hirschfield G.M. Autoimmune liver disease for the non-specialist. BMJ 2009, 339:b3305.
8. Leung P.S., Rossaro L., Davis P.A., et al. Antimitochondrial antibodies in acute liver failure: implications for primary biliary cirrhosis. Hepatology 2007, 46:1436-1442.
9. Bhat M., Guindi M., Heathcote E.J., et al. Transient development of anti-mitochondrial antibodies accompanies autoimmune hepatitis-sclerosing cholangitis overlap. Gut 2009, 58:152-153.
10. Montano-Loza A.J., Carpenter H.A., Czaja A.J. Frequency, behavior, and prognostic implications of antimitochondrial antibodies in type 1 autoimmune hepatitis. J Clin Gastroenterol 2008, 42:1047-1053.
11. Czaja A.J., Carpenter H.A. Autoimmune hepatitis with incidental histologic features of bile duct injury. Hepatology 2001, 34:659-665.
12. Perrillo R.P., Mason A.L., Jacob S., et al. Hepatitis and cholestasis in a middle-aged woman. Hepatology 1996, 24:730-734.
13. Chazouillères O., Wendum D., Serfaty L., et al. Long term outcome and response to therapy of primary biliary cirrhosis-autoimmune hepatitis overlap syndrome. J Hepatol 2006, 44:400-406.
14. Hirschfield G.M., Liu X., Xu C., et al. Primary biliary cirrhosis associated with HLA, IL12A, and IL12RB2 variants. N Engl J Med 2009, 360:2544-2555.
15. Hirschfield G.M., Heathcote E.J., Gershwin M.E. Pathogenesis of cholestatic liver disease and therapeutic approaches. Gastroenterology 2010, 139:1481-1496.